Brenntag Stock Forecast, Price & News

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Brenntag in the last twelve months. There are currently 1 sell rating, 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Brenntag stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BNR, but not buy additional shares or sell existing shares.
View analyst ratings for Brenntag or view top-rated stocks.

Wall Street analysts have given Brenntag a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Brenntag wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Brenntag's stock was trading at €37.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BNR shares have increased by 120.5% and is now trading at €82.52.
View which stocks have been most impacted by COVID-19.

12 analysts have issued twelve-month price objectives for Brenntag's shares. Their forecasts range from €66.00 to €101.00. On average, they expect Brenntag's stock price to reach €85.45 in the next year. This suggests a possible upside of 3.6% from the stock's current price.
View analysts' price targets for Brenntag or view top-rated stocks among Wall Street analysts.

Some companies that are related to Brenntag include Akzo Nobel (AKZOF), Alexium International Group (AJX), Autris (AUTR), BlueFire Renewables (BFRE), Borregaard ASA (BRRDF), Brenntag (BNTGF), Calix (CXL), Carbios SAS (COOSF), Carbonxt Group (CG1), CFOAM (CFO), Chemtrade Logistics Income Fund (CGIFF), Chr. Hansen Holding A/S (CHYHY), Clariant (CLZNY), Corbion (CSNVY) and Daicel (DACHF).
View all of BNR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Brenntag investors own include Brenntag (BNTGF), Check Point Software Technologies (CHKP), Fifth Third Bancorp (FITB), Intel (INTC), AbbVie (ABBV), AmerisourceBergen (ABC), Abbott Laboratories (ABT), Accenture (ACN), Analog Devices (ADI) and American Financial Group (AFG).

Brenntag trades on the FRA under the ticker symbol "BNR."

One share of BNR stock can currently be purchased for approximately €82.52.

Brenntag employs 17,225 workers across the globe.

The official website for Brenntag is www.brenntag.com.

Brenntag is headquartered at Stinnes-Platz 1, MUELHEIM AN DER RUHR, 45472, Germany.

Brenntag's mailing address is Stinnes-Platz 1, MUELHEIM AN DER RUHR, 45472, Germany. The company can be reached via phone at +49-208-78280.